Efficacy, Safety, and Pharmacokinetics of AZD7442 (tixagevimab/cilgavimab) for Prevention of Symptomatic COVID-19: 15-Month Final Analysis of the PROVENT and STORM CHASER Trials
Infectious Diseases and Therapy（2024）
Key words
Tixagevimab,Cilgavimab,COVID-19,Monoclonal antibody,Clinical trial,Prophylaxis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined